Current Trading
The hard work, commitment and entrepreneurism of our employees, in what remains a challenging environment, supported by our focused capital allocation policy has resulted in a strong start to 2021.
Our January-April revenue growth in constant currency was 15%, which comprises organic growth of 10% and 5% from acquisitions. Compared to 2019, on an organic basis, revenues were flat. From a divisional perspective, Knowledge, Health & Nutrition and Connectivity & Products have all shown a very strong organic performance, above the Group average. Industry & Environment grew organically in high single digits and Natural Resources at a low single digit. From a regional perspective, all regions returned to organic growth over the period.
We are pleased with our constant currency Adjusted Operating Income (AOI) performance, which, as expected, is materially ahead of the prior year. Profitability has also increased compared to the comparable period in 2019 reflecting the structural optimization measures taken.
FY 2021 Outlook Remains Unchanged
- Solid organic growth normalizing for the impact of Covid-19
- Improving the Adjusted Operating Income margin
- Strong cash conversion
- Maintaining best-in-class organic return on invested capital
- Accelerate investment into our strategic focus areas with M&A as a key enabler
- At least maintain or grow the dividend
The Format and Agenda of the Investor Days
SGS is hosting its virtual investor day today, May 27, and a 'speed-dating' event on May 28 for analysts and investors to get to know our senior management team.